Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kinetics

NCT01065051 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension, Pulmonary
Ventricular Dysfunction, Left

Interventions

DRUG: Riociguat (Adempas, BAY63-2521)
DRUG: Placebo

Sponsor

Bayer